Aerobic biodegradation of the sulfonamide antibiotic sulfamethoxazole by activated sludge applied as co-substrate and sole carbon and nitrogen source

Chemosphere

Volumn 92, Issue 8, 2013, Pages 969-978

  Müller, Elisabeth ^a   Schüssler, Walter ^b   Horn, Harald ^c   Lemmer, Hilde ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Bavarian Environment Agency   (Germany)

^c KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

Author keywords

3 Amino 5 methyl isoxazole; 3 Amino isoxazole; Hydroxyl N (5 methyl 1,2 oxazole 3 yl)benzene 1 sulfonamide; Isoxazole; Pharmaceutical; Sulfamethoxazole

Indexed keywords

ANTIBIOTICS; BENZENE; DRUG PRODUCTS; METABOLISM; METABOLITES; NITROGEN; ORGANIC CARBON; SULFUR COMPOUNDS;

3-AMINO-5-METHYL-ISOXAZOLE; 3-AMINO-ISOXAZOLE; HYDROXYL-N-(5-METHYL-1,2-OXAZOLE-3-YL)BENZENE-1-SULFONAMIDE; ISOXAZOLES; SULFAMETHOXAZOLE;

BIODEGRADATION;

3 AMINO 5 METHYL ISOXAZOLE; ACETIC ACID; AMMONIUM NITRATE; CARBON; HYDROXYL N (5 METHYL 1,2 OXAZOLE 3 YL)BENZENE 1 SULFONAMIDE; ISOXAZOLE DERIVATIVE; NITROGEN; ORGANIC CARBON; SULFAMETHOXAZOLE; SULFONAMIDE; UNCLASSIFIED DRUG;

ACETATE; ACTIVATED SLUDGE; ADSORPTION; AMMONIUM; ANTIBIOTICS; BIODEGRADATION; DISSOLVED ORGANIC CARBON; METABOLITE; MINERALIZATION; NITRATE; NITROGEN; SUBSTRATE;

ACTIVATED SLUDGE; ARTICLE; BIODEGRADATION; MINERALIZATION;

EID: 84880039916     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2013.02.070     Document Type: Article

References (47)

1. Accinelli C., Koskinen W.C., Becker J.M., Sadowsky M.J. Environmental fate of two sulphonamide antimicrobial agents in soil. J. Agric. Food Chem. 2007, 55:2677-2682.
2. Agersø Y., Petersen A. The tetracycline resistance determinant Tet 39 and the sulphonamide resistance gene sulII are common among resistant Acinetobacter spp. isolated from integrated fish farms in Thailand. J. Antimicrob. Chemoth. 2007, 59:23-27.
3. Al-Ahmad A., Daschner F.D., Kümmerer K. Biodegradability of cefotiam, ciprofloxacin, meropenem, penicillin G, and sulfamethoxazole and inhibition of wastewater bacteria. Arch. Environ. Contam. Toxicol. 1999, 37:158-163.
4. Andreozzi R., Raffaele M., Nicklas P. Pharmaceuticals in STP effluents and their solar photodegradation in aquatic environment. Chemosphere 2003, 50:1319-1330.
5. Baumgarten B., Jährig J., Reemtsma T., Jekel M. Long term laboratory column experiments to simulate bank filtration: factors controlling removal of sulfamethoxazole. Water Res. 2011, 45:211-220.
6. Boreen A., Arnold W.A., McNeill K. Photochemical fate of sulfa drugs in the aquatic environment: sulfa drugs containing five-membered heterocyclic groups. Environ. Sci. Technol. 2004, 38:3933-3940.
7. Bouju H., Ricken B., Beffa T., Corvini P.F., Kolvenbach B.A. Isolation of bacterial strains capable of sulfamethoxazole mineralization from an acclimated membrane bioreactor. Appl. Environ. Microb. 2012, 78:277-279.
8. Carballa M., Omil F., Lema J.M. Calculation methods to perform mass balances of micropollutants in sewage treatment plants. Application to pharmaceutical and personal care products (PPCPs). Environ. Sci. Technol. 2007, 41:884-890.
9. Cervantes F.J., Gutiérrez C.H., López K.Y., Estrada-Alvarado M.I., Meza-Escalante E.R., Texier A.-C., Cuervo F., Gómez J. Contribution of quinone-reducing microorganisms to the anaerobic biodegradation of organic compounds under different redox conditions. Biodegradation 2008, 19:235-246.
10. DEV, German Standard Methods Deutsche Einheitsverfahren zur Wasser-, Abwasser- und Schlammuntersuchung. Physikalische, chemische, biologische und mikrobiologische Verfahren 2000, VCH Verlagsgesellschaft, Weinheim, and Beuth, Berlin.
11. Drillia P., Dokianakis S.N., Fountoulakis M.S., Kornaros M., Stamatelatou K., Lyberatos G. On the occasional biodegradation of pharmaceuticals in the activated sludge process: the example of the antibiotic sulfamethoxazole. J. Hazard. Mater. 2005, 122:259-265.
12. Dytczak M., Londry K., Oleszkiewicz J. Biotransformation of estrogens in nitrifying activated sludge under aerobic and alternating anoxic/aerobic conditions. Water Environ. Res. 2008, 80:47-52.
13. Eibes G., Debernardi G., Feijoo G., Moreira M.T., Lema J.M. Oxidation of pharmaceutically active compounds by a ligninolytic fungal peroxidase. Biodegradation 2011, 22:539-550.
14. Enne V.I., King A., Livermore D.M., Hall L.M. Sulfonamide resistance in Haemophilus influenzae mediated by acquisition of sul2 or a short insertion in chromosomal folP. Antimicrob. Agents Chemother. 2002, 46:1934-1939.
15. Fent K., Weston A.A., Caminada D. Ecotoxicology of human pharmaceuticals. Aquat. Toxicol. 2006, 76:122-159.
16. Field J.A., Cervantes F.J., van der Zee F.P., Lettinga G. Role of quinones in the biodegradation of priority pollutants: a review. Water Sci. Technol. 2000, 42:215-222.
17. Gao J., Ellis L.B., Wackett L.P. The University of Minnesota biocatalysis/biodegradation database: improving public access. Nucleic Acids Res. 2010, 38:D488-D491. http://nar.oxfordjournals.org/.
18. García-Galán M.J., Díaz-Cruz M., Barceló D. Removal of sulfonamide antibiotics upon conventional activated sludge and advanced membrane bioreactor treatment. Anal. Bioanal. Chem. 2012, 404:1505-1515.
19. Gauthier H., Yargeau V., Cooper D.G. Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism. Sci. Total Environ. 2010, 408:1701-1706.
20. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39:3981-3989.
21. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
22. Golet E.M., Xifra I., Siegrist H., Alder A.C., Giger W. Environmental exposure assessment of fluoroquinolone antibacterial agents from sewage to soil. Environ. Sci. Technol. 2003, 37:3243-3249.
23. Hartig, C., 2000. Analytics, occurrence, and behavior of aromatic sulfonamides in the aquatic environment (in German: Analytik, Vorkommen und Verhalten aromatischer Sulfonamide in der aquatischen Umwelt). Thesis. Fakultät III Prozesswissenschaften, Technical University Berlin, Germany, pp. 1-185.
24. Heberer T. Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: a review of recent research data. Toxicol. Lett. 2002, 131:5-17.
25. Heberer T., Massmann G., Fanck B., Taute T., Dünnbier U. Behaviour and redox sensitivity of antimicrobial residues during bank filtration. Chemosphere 2008, 73(4):451-460.
26. Hirsch R., Ternes T., Haberer K., Kratz K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225:109-118.
27. Holm J.V., Ruegge K., Bjerg P.L., Christensen T.H. Occurrence and distribution of pharmaceutical organic compounds in the groundwater down gradient of a landfill (Grindsted, Denmark). Environ. Sci. Technol. 1995, 29:1415-1420.
28. Ingerslev F., Halling-Sørensen B. Biodegradability properties of sulfonamides in activated sludge. Environ. Toxicol. Chem. 2000, 19:2467-2473.
29. Jjemba P.K. The potential impact of veterinary and human therapeutic agents in manure and biosolids on plants grown on arable land: a review. Agr. Ecosyst. Environ. 2002, 93:267-278.
30. Joss A., Zabczynski S., Gobel A., Hoffmann B., Loffler D., McArdell C.S., Ternes T.A., Thomsen A., Siegrist H. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res. 2006, 40:1686-1696.
31. Kreuzinger N., Clara M., Strenn B., Kroiss H. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci. Technol. 2004, 50:149-156.
32. Kümmerer K. Antibiotics in the aquatic environment - a review - part I. Chemosphere 2009, 75:417-434.
33. Larcher S., Yargeau V. Biodegradation of sulfamethoxazole by individual and mixed bacteria. Appl. Microbiol. Biot. 2011, 91:211-218.
34. Li B., Zhang T. Biodegradation and adsorption of antibiotics in the activated sludge process. Environ. Sci. Technol. 2010, 44:3468-3473.
35. Lin K., Gan J. Sorption and degradation of wastewater-associated non-steroidal anti-inflammatory drugs and antibiotics in soils. Chemosphere 2011, 83:240-246.
36. Perez S., Eichhorn P., Aga D.S. Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment. Environ. Toxicol. Chem. 2005, 24:1361-1367.
37. Richardson S.D., Ternes T.A. Water analysis: emerging contaminants and current issues. Anal. Chem. 2011, 83:4614-4648.
38. Sacher F., Lange F.T., Brauch H.J., Blankenhorn I. Pharmaceuticals in groundwaters analytical methods and results of a monitoring program in Baden-Württemberg, Germany. J. Chromatogr., A 2001, 938:199-210.
39. Sharma V.K., Mishra S.K., Nesnas N. Oxidation of Sulfonamide Antimicrobials by Ferrate(VI) [FeVIO42-]. Environ. Sci. Technol. 2006, 40:7222-7227.
40. Shi J., Fujisawa S., Nakai S., Hosomi M. Biodegradation of natural and synthetic estrogens by nitrifying activated sludge and ammonia-oxidizing bacterium Nitrosomonas europaea. Water Res. 2004, 38:2323-2330.
41. Szczepanowski R., Linke B., Krahn I., Gartemann K.H., Gutzkow T., Eichler W., Puhler A., Schluter A. Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of wastewater treatment plant bacteria showing reduced susceptibility to selected antibiotics. Microbiology 2009, 155:2306-2319.
42. Ternes T., Joss A. Human pharmaceuticals, hormones and fragrances: The challenge of micropollutants in urban water management 2007, IWA Publishing, London. first ed.
43. Thiele-Bruhn S., Beck I.-C. Effects of sulfonamide and tetracycline antibiotics on soil microbial activity and microbial biomass. Chemosphere 2005, 59:457-465.
44. Trovó A.G., Nogueira R.F.P., Agüera A., Sirtori C., Fernandez-Alba A.R. Photodegradation of sulfamethoxazole in various aqueous media: persistence, toxicity and photoproducts assessment. Chemosphere 2009, 77:1292-1298.
45. Underwood J.C., Harvey R.W., Metge D.W., Repert D.A., Baumgartner L.K., Smith R.L., Roane T.M., Barber L.B. Effects of the antimicrobial sulfamethoxazole on groundwater bacterial enrichment. Environ. Sci. Technol. 2011, 45:3096-3101.
46. van der Ven A.J., Vree T.B., van Ewijk-Beneken Kolmer E.W., Koopmans P.P., van der Meer J.W. Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole. Br. J. Clin. Pharmaco. 1995, 39:621-625.
47. Witte W. International dissemination of antibiotic resistant strains of bacterial pathogens. Infect. Genet. Evol. 2004, 4:187-191.